Hedef Kontrollü İnfüzyon

Major DJ- Chirurgia Infusora Placidis CL: Vivorium Dubiis Impugnata, cum Modesta, ad Eadem, Responsione.Kiloni, 1667, cited Vandam LD History of Anesthetic Practice, in: RD Miller- Anesthesia, 5thEd, Philadelphia, Churchill-Livingstone. 2000;1-11.

Wood A. A new method of treating neuralgia by the direct application of opiates to the painful points. Med Surg J. 1855;82: 265-281.

Pray PC- Etudes, Cliniques sur l´Anesthésie Chirurgicale par la Methode des Injection de Chloral dans le Veines. Paris, JB Balliere, 1875, cited Vandam LD- History of Anesthetic Practice in: Miller RD- Anesthesia, 5 Ed, Philadelphia, Churchill Livingstone. 2000;1-11.

Nora FS. Total intravenous anesthesia as a target-controlled infusion. An evolutive analysis. Revista brasileira de anestesiologia. 2008;58(2):179-192.

Pico LJ. An appliance to facilitate the administration of intravenous anaesthesia by continuous drip. Anesthesiology. 1944;5: 411-2.

Ledowski T, Bein, B, Hanss R, et al. Neuroendocrine Stress Response and Heart Rate Variability: A Comparison of Total Intravenous Versus Balanced Anesthesia.Anesthesia & Analgesia: December. 2005;101(6):1700-1705. doi:10.1213/01. ane.0000184041.32175.14.

Dal H, İzdeş S, Kesimci E ve ark. Kolonoskopide Sedasyon İçin Propofolün Aralıklı Bolus veya Hedef Kontrollü İnfüzyon Yöntemiyle Uygulanmasının Karşılaştırılması. Türk Anest Rean Der Dergisi. 2011;39(3):134- 142. doi:10.5222/JTAICS.2011.134

Absalom AR, Glen JB; Zwart GJC,et al. "Target-Controlled Infusion". Anesthesia & Analgesia. 2016;122(1): 70-78. doi:10.1213/ANE.0000000000001009

Coşkun ve ark. Hedef kontrollü infüzyon ve TİVA. Anestezi Dergisi. 2012;20(1):1-12.

Schüttler J, Stoeckel H, Schwilden H. Pharmacokinetic and pharmacodynamic modelling of propofol in volunteers and surgical patients. Postgraduate Medical Journal. 1985;61(suppl3):53.

Karcı A. Anestezide Farmakolojinin Temel Prensipleri. Çeviri: Aydın D In: Miller RD (ed). Miller Anestezi, Çeviri editörü: Aydın D, Güven Kitabevi, İzmir. 2010;67-104.

Struys M, Versichelen L, Byttebier G, Mortier E, Moerman A, Rolly G. Clinical usefulness of bispectral index for titrating propofol effect-site concentration. Anaesthesia. 1998;53:4-12.

Absolom AR, Sttruys MRF. An overwiev of TCI &TIVA. Gent, Academia Press, 2nd ed. 2007;1-108.

Theil DR, Stanley TE, White WD, et al. Midazolam and fentanyl continuous infusion anesthesia for cardiac surgery: A comparasion of Computer-Assisted Versus Manuel Infusion Systems. Journal of Cardiothoracic and Vascular Anesthesia. 1993;7(3):300-306.

Frölich MA, Dennis DM, Shuster JA, et al. Precision and bias of target controlled propofol infusion for sedation. Br J Anaesth. 2005;94:434-437. http://dx.doi.org/10.1093/bja/aei081 PMid:15681587

Akcaboy ZN, Akcaboy EY, Albayrak D, ve ark. Can remifentnil be a better choice than propofol for colonoscopy during monitored anesthesia care? Acta Anaesthesiol Scand. 2006;50:736- 734.

Roberts FL, Dixon J, Lewis GT, et al. Induction and maintenance of propofol anaesthesia. A manual infusion scheme. Anaesthesia. 1988;43(Suppl):14-17.

Guarracino F, Lapolla F, Cariello C et al. Target contolled infusion:TCI, Minerva Anestesiologica. 01 Jun 2005;71(6):335-337.

Hu C, Horstman DJ, Shafer SL. Variability of target-controlled infusion is less than the variability after bolus injection. Anesthesiology. 2005;102:639-645.

Struys M, De Smet T. Principles of drug actions: target-controlled infusions and closed-loop administration. In: Evers AS, Maze M, Kharasch ED, eds. Anesthetic Pharmacology: Basic principles and Clinical Practice. Cambridge, UK: Cambridge University Press. 2011:103–122.

Struys M, De Smet T, Glen JB. The History of Target-Controlled Infusion.Anesthesia & Analgesia: January. 2016;122(1):56-69 doi: 10.1213/ANE.0000000000001008

Schüttler J, Kloos S, Schwilden H, et al. Total intravenous anaesthesia with propofol and alfentanil by computer-assisted infusion. Anaesthesia. 1988;43(suppl):2-7.

Tackley RM, Lewis GT, Prys-Roberts C, et al. Computer controlled infusion of propofol. Br J Anaesth. 1989;62:46-53.

Jacobs JR. Analytical solution to the three-compartment pharmacokinetic model. IEEE Trans Biomed Eng. 1988;35:763-765.

Shafer SL, Varvel JR, Aziz N, et al. Pharmacokinetics of fentanyl administered by computer-controlled infusion pump. Anesthesiology. 1990;73:1091-102.

Glass PSA, Glen JB, Kenny GNC, et al. Nomenclature for computer-assisted infusion devices. Anesthesiology.1997;86:1430-1431.

Marsh B, White M, Morton N, et al. Pharmacokinetic model driven infusion of propofol in children. Br J Anaesth. 1991;67:41-48.

Gepts E, Camu F, Cockshott ID, et al. Disposition of propofol administered as constant rate intravenous infusions in humans. Anesth Analg. 1987;66(12):1256-1263.

Absalom AR, Mani V, De Smet T, et al. Pharmacokinetic models for propofol-defining and illuminating the devil in the detail. British Journal of Anaesthesia. 2009;103(1):26–37 doi:10.1093/bja/aep143

Minto CF, Schnider TW, Egan TD et al. Influence of age and gender on the pharmacokinetics and pharmacodynamics of remifentanil. I. Model development. Anesthesiology. 1997;86:10-23.

Schnider TW, Minto CF, Bruckert H, et al. Population pharmacodynamic modeling and covariate detection for central neural blockade. Anesthesiology. 1996;85:502-512.

Baker MT, Naguib M, Warltier DC. Propofol: The Challenges of Formulation. Anesthesiology. 2005;103:860-876. https://doi.org/10.1097/00000542-200510000-00026

Absolom AR, Struys MRF. An overview of TCI and TIVA. Gent, Academia Press, 2nd ed. 2007;1-108.

Swinhoe CF, Peacock JE, Glen JB,et al. Evaluation of the predictive performance of a 'Diprifusor' TCI system. Anaesthesia.1998;53 (Suppl 1):61-67.

Passot S, Servin F, Allary R, et al. Target-controlled versus manually-controlled infusion of propofol for direct laryngoscopy and bronchoscopy. Anesth Analg. 2002;94(5):1212-1216.

Macquaire V, Cantraine F, Schmartz D, et al. Target-controlled infusion of propofol induction with or without plasma concentration constraint in high-risk adult patients undergoing cardiac surgery. Acta Anaesthesiol Scand. 2002;46:1010-1016.

Struys M, Versichelen L, Rolly G. Influence of pre-anaesthetic medication on target propofol concentration using a 'Diprifusor' TCI system during ambulatory surgery. Anaesthesia. 1998;53 Suppl 1:68-71.

38- Servin FS, Marchand-Maillet F, Desmonts JM. Influence of analgesic supplementation on the target propofol concentrations for anaesthesia with 'Diprifusor' TCI. Anaesthesia. 1998;53 Suppl 1:72-76.

Coşkun D, Akçalı D, Çelebi H. Hedef Kontrollü İnfüzyon Cihazı İle Total İntravenöz Anestezi: Propofol ve Remifentanilin Uyumlu Beraberliği. Anestezi Dergisi. 2012;20(1):1-12.

Albertin A, Poli D, La Colla L, et al. Preditive performance of ‘Servin’s formula’ during BIS-guided propofol-remifentanil target -controlled infusion in morbidly obese patients. Br J Anaesth. 2007;98:66-75.

Cheymol G. Effect of obesity on pharmakokinetics implications for drug therapy. Clin Pharmacokinet. 2000;39:215-231.

Cortínez LI; De la Fuente N; Eleveld DJ; et al. Performance of Propofol Target-Controlled Infusion Models in the Obese Pharmacokinetic and Pharmacodynamic Analysis Anesthesia & Analgesia: August 2014;119(2):302-310. doi: 10.1.213/ANE.0000000000000317

Cortínez LI, Sepúlveda P, Rolle A, et al. Effect-Site Target Controlled Infusion in the Obese : Model Derivation and Performance Assessment. Anesth Analg. 2018;127(4):865-872. doi: 10.1213/ANE.0000000000002814

Lee YH, Choi GH, Jung KW, et al. Predicitive performance of the modified Marsh and Schnider models for propofol in underweight patients undergoing general anaesthesia using target-controlled infusion. British Journal of Anaesthesia. 2017;118(6) :883-891.

Yi JM, Doh I, Lee SH, et al. Predictive performance of a new pharmacokinetic model for propofol in underweight patients during target-controlled infusion. Acta Anaesthesiologica Scandinavica. 2019;63:448-454.

Morton NS. Total Intravenous Anesthesia (TIVA) and Target Controlled Infusions (TCI) in Children. Curr Anesthesiol Rep. 2013;(3):37-41. doi 10.1007/s40140-012-0005-2

Kataria BK, Ved SA, Nicodemus HF, et al. The pharmacokinetics of propofol in children using three different data analysis approaches. Anestheiology. 1994;80:104-122.

Absolom A, Amotike D, Lal A, et al. Accuracy of the’Paedfuser’ in children undergoing cardiac surgery or catheterization. Br J Anaesth. 2003;91:507-513.

Wan Hassan WMN, Mansor A, Zaini RHM. Anesthesia using target-controlled infusion of propofol during elective pediatric surgery: Kataria versus Paedfusor pharmacokinetic model. Anaesth Pain & Intensive Care. 2018;22(2):207-211.

Ji SH, Lee JH, Cho JY, et al. External Validation of a Pharmacokinetic Model of Propofol for Target-Controlled Infusion in Children under Two Years Old. J Korean Med Sci. 2020;35(11): e70. doi: 10.3346 / jkms.2020.35.e70

Scott JC, Stanski DR. Decreased fentanyl and alfentanil dose requirements with age. A simultaneous pharmacokinetic and pharmacodynamic evaluation. J Pharmacol Exp Ther. 1987;240:159-166.

Gepts E, Shafer SL, Camu F, et al. Linearity of pharmacokinetics and model estimation of sufentanil. Anesthesiology. 1995;83:1194-1204.

Minto CF, Schnider TW, Shafer SL. Pharmacokinetics and pharmacodynamics of remifentanil. II. Model application. Anesthesiology. 1997;86:24-33.

Servin FS, Billard V. Remifentanil and Other Opioids. In: Schüttler J., Schwilden H. (eds) Modern Anesthetics. Handbook of Experimental Pharmacology. 2008;182:283-311.

Angst MS. Intraoperative Use of Remifentanil for TIVA: Postoperative Pain, Acute Tolerance, and Opioid-Induced Hyperalgesia. Journal of Cardiothoracic and Vascular Anesthesia. 2015;29 supp1:16-22.

Moerman AT, Herregods LL, De Vos MM, et al. Manual Versus Target-Controlled Infusion Remifentanil Administration in Spontaneously Breathing Patients. Anesthesia & Analgesia. 2009;108:828-834.

Minto CF, Schnider TW, Egan TD, et al. Influence of Age and Gender on the Pharmacokinetics and Pharmacodynamics of Remifentanil: I. Model Development.Anesthesiology. 1997;86:10-23.

Eleveld DJ, Colin P, Absolom AR, et al. Target-controlled-infusion models for remifentanil dosing consistent with approved recommendations. British Journal of Anaesthesia. 2020;125(4):483-491.

Gruenbaum SE, F. Bilotta. Propofol versus thiopental use in patients undergoing craniotomy. Minerva Anestesiologica. 2014;80, no 7: 753-755.

Rozec B, Floch H, Berlivet P, et al. Propofol versus thiopental by target controlled infusion in patients undergoing craniotomy. Minerva Anestesiologica. 2013;80(7):761-768.

61. Gray C, Swinhoe CF, Myint Y;et al. Target controlled infusion of ketamin as analgesia for TIVA with propofol. Can J Anesth. 1999;46:957-961.

Bourgoin A, Albanése J, Léone M, et al. Effects of sufentanil or ketamine administered in target-controlled infusion on the cerebral hemodynamics of severely brain-injured patients. Crit Care Med. 2005;33:1109-1113.

Lin YJ, Wang YC, Huang HH, et al. Target-controlled propofol infusion with or without bispectral index monitoring of sedation during advanced gastrointestinal endoscopy. Journal of Gastroenterology and Hepatology. 2020;35(7):1189-1195.

MH Chiang, SC Wu, CH You, et al. Target-controlled infusion vs. manually controlled infusion of propofol with alfentanil for bidirectional endoscopy: a randomized controlled trial. Endoscopy. 2013;45:907-914.

Chang YT, Tsai TC, Hsu H, et al. Sedation for gastrointestinal endoscopy with the application of target-controlled infusion. Turk J Gastroenterol 2015;26:417-422.

Kapoor H. Anaesthesia for endoscopic retrograde cholangiopancreatography. Acta Anaesthesiol Scand. 2011;55:918-926.

Motiaa Y, Bensghir M, Jaafari A, et al. Anesthesia for endoscopic retrograde cholangiopancreatography: target-controlled infusion versus standard volatile anesthesia. Annals of Gastroenterology. 2016;29(4):530-535.

Mazanikov M, Udd M, Kylänpää L, et al. A randomized comparison of target-controlled propofol infusion and patient-controlled sedation during ERCP. Endoscopy 2013;45:915-919.

Gillham MJ, Hutchinson RC, Carter R, et al. Patient-maintained sedation for ERCP with a target-controlled infusion of propofol: A pilot study. Gastrointest Endosc 2001;54:14-17.

Chi X, Pan J, Cai J, et al. Pharmacokinetic Analysis of Propofol Target-Controlled Infusion Models in Chinese Patients with Hepatic Insufficiency . Med Sci Monit. 2018;24:6925-6933. doi: 10.12659/MSM.910103

Ogawa T, Tomoda T, Kato H, et al. Propofol sedation with a target-controlled infusion pump in elderly patients undergoing ERCP. 2020;92(2):301-307. doi: https://doi.org/10.1016/j.gie.2020.03.002

Fanti L, Agostoni M, Arcidiacono P.G, et al. Target-controlled infusion during monitored anesthesia care in patients undergoing EUS: Propofol alone versus midazolam plus propofol: A prospective double-blind randomised controlled trial. Digestive and Liver Disease. 2007;39(1): 81-86.

Imashuku Y, Kitagawa H, Kojima A, et al. Management for electroconvulsive therapy using target-controlled infusion of propofol. Masui. The Japanese Journal of Anesthesiology. 2008;57(7):889-891.

Maeda T, Enomoto T, Kamiyama Y, et al. Anesthetic management for electroconvulsive therapy using rocuronium bromide and sugammadex sodium in a patient with suspected malignant syndrome. Masui The Japanese Journal of Anesthesiology. 2011;60(12):1384-1386.

Imashuku Y, Kanemoto K, Senda M, Matsubara M. Relationship between blood levels of propofol and recovery of memory in electroconvulsive therapy. Psychiatry Clin Neurosci. 2014;68(4):270-274.

Hsieh ML, Lu YT, Lin CC, et al. Comparison of the target-controlled infusion and the manual infusion of propofol anesthesia during electroconvulsive therapy: an open-label randomized controlled trial. BMC Psychiatry. 2021;21:71. doi: https://doi.org/10.1186/s12888-021-03069-6